No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Barretts Esophagus is a condition in which the cells of the lower esophagus become abnormal due to chronic acid reflux. It is a common complication of gastroesophageal reflux disease (GERD) and is a major risk factor for esophageal cancer. Treatment for Barretts Esophagus typically involves lifestyle changes, medications, and endoscopic procedures.
The Barretts Esophagus market is a subset of the Gastroenterology market, which is estimated to be worth billions of dollars. The Barretts Esophagus market is expected to grow due to increasing prevalence of GERD, rising awareness of the condition, and the availability of new treatments.
Companies in the Barretts Esophagus market include AstraZeneca, Allergan, Boston Scientific, Olympus, and Cook Medical. Show Less Read more
